Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationales for treating IgA nephropathies.

E N Wardle

    Renal Failure
    |March 16, 2000
    PubMed
    Summary
    This summary is machine-generated.

    IgA nephropathy (IgA) pathophysiology involves eicosanoids, angiotensin II, and reactive oxygen species. Therapies include ACE inhibitors, corticosteroids, and potentially new agents targeting specific pathways to slow disease progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    FRACTURES OF BOTH BONES OF THE LEG.

    British medical journal·2010
    Same author

    Pathogenesis of acute renal failure: shock-kidneys.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
    Same author

    Understanding immunoglobulin IgA nephropathy.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
    Same author

    Advances in the pathogenesis of glomerulonephritides.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
    Same author

    Ways of treating IgA nephropathies.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
    Same author

    Coxibs and caution.

    Journal of the Royal Society of Medicine·2005

    Area of Science:

    • Nephrology
    • Immunology
    • Pathophysiology

    Background:

    • Immunoglobulin A (IgA) nephropathy is a primary glomerular disease.
    • Pathophysiological mechanisms involve eicosanoids, angiotensin II, and reactive oxygen species.

    Purpose of the Study:

    • To outline the pathophysiology of IgA nephropathy.
    • To highlight potential therapeutic targets and strategies.

    Main Methods:

    • Review of existing literature on IgA nephropathy pathophysiology.
    • Discussion of current and potential future therapeutic interventions.

    Main Results:

    • Eicosanoids, angiotensin II, and reactive oxygen species play key roles.
    • ACE inhibitors and early corticosteroid use are established therapies.

    Related Experiment Videos

  • Emerging therapies include thromboxane/leukotriene/PAF antagonists, antioxidants, PDGF aptamers, and heparins.

    • Conclusions:

    • Understanding pathophysiology guides therapeutic development for IgA nephropathy.
    • Combination therapies targeting multiple pathways may offer improved outcomes.
    • Further research into novel agents like PDGF aptamers is warranted.